MD3121F1 - Method of viral hepatitis B prophylaxis - Google Patents
Method of viral hepatitis B prophylaxis Download PDFInfo
- Publication number
- MD3121F1 MD3121F1 MDA20050280A MD20050280A MD3121F1 MD 3121 F1 MD3121 F1 MD 3121F1 MD A20050280 A MDA20050280 A MD A20050280A MD 20050280 A MD20050280 A MD 20050280A MD 3121 F1 MD3121 F1 MD 3121F1
- Authority
- MD
- Moldova
- Prior art keywords
- viral hepatitis
- prophylaxis
- vaccine
- pacovirin
- tablets
- Prior art date
Links
- 208000002672 hepatitis B Diseases 0.000 title abstract 3
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 abstract 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention refers to medicine, in particular to the infectious diseases and may be used for viral hepatitis B prophylaxis. Summary of the invention consists in that it is administered the viral hepatitis B vaccine and Pacovirin preparation in tablets, in a dose of 50,0 mg of active substance, during 90 days from the day of administration of the vaccine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20050280A MD3121G2 (en) | 2005-09-15 | 2005-09-15 | Method of viral hepatitis B prophylaxis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20050280A MD3121G2 (en) | 2005-09-15 | 2005-09-15 | Method of viral hepatitis B prophylaxis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD3121F1 true MD3121F1 (en) | 2006-08-31 |
| MD3121G2 MD3121G2 (en) | 2007-03-31 |
Family
ID=36992845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20050280A MD3121G2 (en) | 2005-09-15 | 2005-09-15 | Method of viral hepatitis B prophylaxis |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD3121G2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD223Z (en) * | 2010-03-05 | 2011-02-28 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method for revaccination of children against viral hepatitis B |
| MD4177C1 (en) * | 2011-01-14 | 2013-02-28 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for vaccination against hepatitis B of persons with immunodeficiency |
| MD596Z (en) * | 2012-10-09 | 2013-09-30 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for treating chronic viral hepatitis C in children |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD670G2 (en) * | 1996-05-08 | 1997-08-31 | Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova | Remedy with immunomodulator activity |
| MD1875G2 (en) * | 1999-11-01 | 2002-09-30 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method of treatment of the acute viral hepatitis B |
| MD2053C2 (en) * | 2001-07-10 | 2003-07-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Remedy with interferon inducing action |
| MD2549G2 (en) * | 2003-07-18 | 2005-08-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method of treatment of the chronic viral hepatitis C |
-
2005
- 2005-09-15 MD MDA20050280A patent/MD3121G2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD3121G2 (en) | 2007-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD4430B1 (en) | Compositions and methods for treating hepatitis C virus | |
| MX2012007410A (en) | Novel antiviral compounds. | |
| TW200630093A (en) | Dose forms | |
| NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| MX2009003372A (en) | Non-mucoadhesive film dosage forms. | |
| MY154683A (en) | Pharmaceutical composition for a hepatitis c viral protease inhibitor | |
| WO2010116385A3 (en) | Pharmaceutical compositions for alleviating unpleasant taste | |
| PA8744101A1 (en) | METHOD OF COMBINED THERAPY FOR THE TREATMENT OF INFECTION BY THE VIRUS OF HEPATITIS C AND PHARMACEUTICAL COMPOSITIONS FOR USE IN SUCH THERAPY | |
| AR045289A1 (en) | ORAL DOSAGE FORM OF CONTROLLED RELEASE THAT INCLUDES 4- (2-DI-N-PROPILAMINOETIL) - 2 (3H) -INDOLONE (ROPI-NIROL) AND USE OF SUCH DOSAGE FORM FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
| ES2570401T3 (en) | Methods of treatment using single doses of oritavancin | |
| SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
| EA200800467A1 (en) | APPLICATION OF COMPLEX ETHERS OF HYDROXYBENZOIC ACID AND ANALOGUES FOR OBTAINING MEDICINES FOR THE PREVENTION AND TREATMENT OF VIRAL INFECTION | |
| MX2013003523A (en) | Low dose pharmaceutical composition comprising zanamivir. | |
| WO2006044968A3 (en) | Combination therapy for treating viral infections | |
| MY166524A (en) | Therapeutic substance, pharmaceutical composition, helicobacter pylori growth inhibitor and method for conducting anti-helicobacter therapy | |
| SE0401612D0 (en) | Inhaling using pods | |
| MD3121F1 (en) | Method of viral hepatitis B prophylaxis | |
| JP2020536098A5 (en) | ||
| RU2013120345A (en) | NEW METHODS FOR TREATING INFECTIONS CAUSED BY HEPATITIS C VIRUS | |
| SE0102887D0 (en) | New formulation | |
| UA95299C2 (en) | Prophylactic or therapeutic agent for viral disease caused by hepatitis c virus | |
| UA93365C2 (en) | Injectable preparations of diclofenic and its pharmaceutically acceptable salts, and processes for the preparation thereof | |
| TW200618807A (en) | Prevention and therapeutical agent for hepatitis C virus infection | |
| MD20060037A (en) | Method of treating the acute viral hepatitis C |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |